Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications

被引：0
|
作者：
Jillan Cantor Sackett
Ronald A. Weller
Elizabeth B. Weller
机构：
[1] Thomas Jefferson University Hospital,Department of Psychiatry
来源：
Current Psychiatry Reports | 2009年 / 11卷
关键词：
Pregnant Woman; Major Depressive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitor; Maternal Depression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
This paper reviews the risks and benefits of using selective serotonin reuptake inhibitors (SSRIs) in pregnant women. The effects of SSRI use on pregnant women and fetuses are discussed, and the need for SSRI treatment is explained. Persistent pulmonary hypertension of the newborn, teratogenic risks of SSRI treatment during pregnancy, neonatal adaptations, and long-term outcomes for children whose mothers used SSRIs during pregnancy are specifically considered. Due to conflicting results from current studies, there are no clear guidelines for SSRI treatment in pregnancy. Patients and doctors must discuss together the risks and benefits of SSRI use during pregnancy and decide on a course of treatment. Potential risks must be balanced against the effects of untreated maternal depression.
引用
收藏
页码：253 / 257
页数：4
相关论文
共 50 条
  • [1] Selective Serotonin Reuptake Inhibitor Use During Pregnancy and Possible Neonatal Complications
    Sackett, Jillan Cantor
    Weller, Ronald A.
    Weller, Elizabeth B.
    CURRENT PSYCHIATRY REPORTS, 2009, 11 (03) : 253 - 257
  • [2] Pregnancy Complications and Neonatal Mortality in a Serotonin Transporter Null Mouse Model: Insight Into the Use of Selective Serotonin Reuptake Inhibitor During Pregnancy
    Domingues, Rafael R.
    Wiltbank, Milo C.
    Hernandez, Laura L.
    FRONTIERS IN MEDICINE, 2022, 9
  • [3] Serotonin Reuptake Inhibitor Use During Pregnancy
    Rasminsky, Sonya
    Burt, Vivien K.
    JAMA PSYCHIATRY, 2017, 74 (05) : 538 - 539
  • [4] Serotonin Hypothesis of Autism: Implications for Selective Serotonin Reuptake Inhibitor Use during Pregnancy
    Harrington, Rebecca A.
    Lee, Li-Ching
    Crum, Rosa M.
    Zimmerman, Andrew W.
    Hertz-Picciotto, Irva
    AUTISM RESEARCH, 2013, 6 (03) : 149 - 168
  • [5] Serotonin reuptake inhibitor use in pregnancy and the neonatal behavioral syndrome
    Jordan, Allison E.
    Jackson, Gregory L.
    Deardorff, Daralynn
    Shivakumar, Geetha
    McIntire, Donald D.
    Dashe, Jodi S.
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2008, 21 (10): : 745 - 751
  • [6] Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior
    Zeskind, PS
    Stephens, LE
    PEDIATRICS, 2004, 113 (02) : 368 - 375
  • [7] Serotonin reuptake inhibitor use in pregnancy and the neonatal behavioral syndrome
    Jordan, Allison E.
    Jackson, Gregory L.
    Deardorff, Daralynn
    Shivakumar, Geetha
    Mcintire, Donald D.
    Dashe, Jodi S.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 197 (06) : S83 - S83
  • [8] Selective Serotonin Reuptake Inhibitor Exposure in Pregnancy and Neonatal Adverse Events
    Dubnov-Raz, Gal
    Koren, Gideon
    Finkelstein, Yaron
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2010, 164 (04): : 394 - 394
  • [9] Recent Trends in Selective Serotonin Reuptake Inhibitor Use in Pregnancy
    Wichman, Christina L.
    Fothergill, Amy
    Moore, Katherine M.
    Lang, Tara R.
    Heise, Robert H., Jr.
    Watson, William J.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (06) : 714 - 716
  • [10] Maternal use of selective serotonin reuptake inhibitors during pregnancy and neonatal bone density
    Dubnov-Raz, Gal
    Hemila, Harri
    Vurembrand, Yael
    Kuint, Jacob
    Maayan-Metzger, Ayala
    EARLY HUMAN DEVELOPMENT, 2012, 88 (03) : 191 - 194
12345